LOS ANGELES - The Lundquist Institute announced today a new study published in JAMA (Journal of the American Medical Association) which examined the link between hormonal therapy, particularly estrogen and progestin, and the incidence of breast cancer mortality. The team found that the use of estrogen alone among women who had a prior hysterectomy resulted in a lower rate of breast cancer incidence and mortality.

Investigator(s): Charles Grob, MD

LOS ANGELES – An anonymous donor has committed $1.75 million to The Lundquist Institute for Biomedical Innovation in Torrance, CA to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The donation will also support education and outreach programs related to the use of psilocybin within the field of palliative care.  

Investigator(s): Matthew Budoff, MD

LOS ANGELES – A team of investigators from The Lundquist Institute, led by renowned cardiac researcher Matthew Budoff, MD, has been awarded a $3 million R-01 grant award from the National Institutes of Health (NIH) to explore a better way to treat those with heart disease.  This will be accomplished by determining whether calcification outside the heart has an impact on the likelihood of developing heart disease and stroke.  These findings could have a significant, direct and positive impact on current medical practices, delivering appropriate preventative treatment early on and emphasizing